−1.80TWD
−92.11 MTWD
About ADVAGENE BIOPHARMA CO LTD
Sector
Industry
CEO
Yu Shen Hsu
Website
Headquarters
Taipei
Founded
2006
ISIN
TW0006709009
FIGI
BBG00MMP4V35
Advagene Biopharma Co., Ltd. engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy. The company was founded on September 19, 2006 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6709 is 24.95 TWD — it has decreased by 6.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange ADVAGENE BIOPHARMA CO LTD stocks are traded under the ticker 6709.
6709 stock is 27.63% volatile and has beta coefficient of 0.15. Check out the list of the most volatile stocks — is ADVAGENE BIOPHARMA CO LTD there?
Yes, you can track ADVAGENE BIOPHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
6709 stock has risen by 50.30% compared to the previous week, the month change is a 26.01% rise, over the last year ADVAGENE BIOPHARMA CO LTD has showed a 18.26% decrease.
6709 net income for the last quarter is −45.48 M TWD, while the quarter before that showed −46.63 M TWD of net income which accounts for 2.46% change. Track more ADVAGENE BIOPHARMA CO LTD financial stats to get the full picture.
Today ADVAGENE BIOPHARMA CO LTD has the market capitalization of 1.43 B, it has decreased by 6.70% over the last week.
No, 6709 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6709 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADVAGENE BIOPHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADVAGENE BIOPHARMA CO LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADVAGENE BIOPHARMA CO LTD stock shows the sell signal. See more of ADVAGENE BIOPHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.